AU2007215211B2 - Methoxypolyethylene glycol thioester chelate and uses thereof - Google Patents

Methoxypolyethylene glycol thioester chelate and uses thereof Download PDF

Info

Publication number
AU2007215211B2
AU2007215211B2 AU2007215211A AU2007215211A AU2007215211B2 AU 2007215211 B2 AU2007215211 B2 AU 2007215211B2 AU 2007215211 A AU2007215211 A AU 2007215211A AU 2007215211 A AU2007215211 A AU 2007215211A AU 2007215211 B2 AU2007215211 B2 AU 2007215211B2
Authority
AU
Australia
Prior art keywords
compound
pharmaceutically acceptable
patient
cooch
free radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007215211A
Other languages
English (en)
Other versions
AU2007215211A1 (en
Inventor
Frank A. Lattanzio
Karl A. Schellenberg
James Shaeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Publication of AU2007215211A1 publication Critical patent/AU2007215211A1/en
Application granted granted Critical
Publication of AU2007215211B2 publication Critical patent/AU2007215211B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Steroid Compounds (AREA)
AU2007215211A 2006-02-14 2007-02-14 Methoxypolyethylene glycol thioester chelate and uses thereof Ceased AU2007215211B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77287406P 2006-02-14 2006-02-14
US60/772,874 2006-02-14
PCT/US2007/003682 WO2007095178A2 (en) 2006-02-14 2007-02-14 Methoxypolyethylene glycol thioester chelate and uses thereof

Publications (2)

Publication Number Publication Date
AU2007215211A1 AU2007215211A1 (en) 2007-08-23
AU2007215211B2 true AU2007215211B2 (en) 2010-08-26

Family

ID=38372058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007215211A Ceased AU2007215211B2 (en) 2006-02-14 2007-02-14 Methoxypolyethylene glycol thioester chelate and uses thereof

Country Status (8)

Country Link
US (3) US8008347B2 (enExample)
EP (2) EP2428234A1 (enExample)
JP (2) JP5138612B2 (enExample)
CN (1) CN101394844A (enExample)
AT (1) ATE552833T1 (enExample)
AU (1) AU2007215211B2 (enExample)
CA (1) CA2642453A1 (enExample)
WO (1) WO2007095178A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5138612B2 (ja) * 2006-02-14 2013-02-06 イースタン バージニア メディカル スクール メトキシポリエチレングリコールチオエステルキレートおよびその使用
JP2010100615A (ja) * 2008-09-25 2010-05-06 Santen Pharmaceut Co Ltd ポリアルキレングリコールを有効成分として含有する網膜疾患の予防又は治療剤
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用
JP6086576B2 (ja) * 2012-04-24 2017-03-01 公立大学法人首都大学東京 抗酸化剤
WO2018236221A2 (en) * 2017-06-03 2018-12-27 Can Holding B.V. Neurodegenerative peptide deposit dissolution

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020373A (en) * 1995-10-20 2000-02-01 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
JP2722250B2 (ja) 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤
EP0955044B1 (en) * 1995-06-26 2005-11-16 Chelator LLC Method of inhibiting bacterial or fungal growth using a complexing agent
AU7454796A (en) 1995-10-20 1997-05-07 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury
WO2004058289A1 (en) * 2002-12-20 2004-07-15 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
JP5138612B2 (ja) * 2006-02-14 2013-02-06 イースタン バージニア メディカル スクール メトキシポリエチレングリコールチオエステルキレートおよびその使用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020373A (en) * 1995-10-20 2000-02-01 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury

Also Published As

Publication number Publication date
EP1986631A2 (en) 2008-11-05
CA2642453A1 (en) 2007-08-23
EP1986631A4 (en) 2010-10-27
AU2007215211A1 (en) 2007-08-23
WO2007095178A3 (en) 2008-04-17
US7388028B2 (en) 2008-06-17
EP2428234A1 (en) 2012-03-14
WO2007095178A2 (en) 2007-08-23
US20090306205A1 (en) 2009-12-10
US20080039524A1 (en) 2008-02-14
US8796336B2 (en) 2014-08-05
JP2012031173A (ja) 2012-02-16
JP2009527474A (ja) 2009-07-30
ATE552833T1 (de) 2012-04-15
US8008347B2 (en) 2011-08-30
CN101394844A (zh) 2009-03-25
JP5138612B2 (ja) 2013-02-06
EP1986631B1 (en) 2012-04-11
US20120016030A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
AU2001236856B2 (en) Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
ES2964818T3 (es) Profármacos de abiraterona
EP1140745B1 (en) Colchinol derivatives as vascular damaging agents
AU737900B2 (en) Choline esters of fatty acids and their use in the treatment of stroke
US8796336B2 (en) Methoxypolyethylene glycol chelate and uses thereof
JP2012520342A (ja) 代謝障害を処置するのに有用な抗炎症剤および抗酸化剤のコンジュゲート
CN104203901A (zh) 治疗炎症的组合物和方法
IL143709A (en) Use of androgen receptor suppressors
US20190210969A1 (en) Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagitis
CA2960750A1 (en) Compositions and methods for treatment of prostate carcinoma
US20190307726A1 (en) Pharmaceutical formulations
EP1981862B1 (en) Lanthionine-related compounds for the treatment of inflammatory diseases
IL193774A (en) Pharmaceutical compositions containing a 3,5-seco-4-norcholestane derivative
EP3866773B1 (en) Carbon monoxide prodrugs for the treatment of medical disorders
HUE027711T2 (en) An aqueous formulation of improved stability of (E) -4-carboxystyril-4-chlorobenzylsulfone
CA2935933A1 (en) Method of treating liver disorders
US12325688B2 (en) Gingerenone A prodrugs as sensotherapeutics and methods of use
US6372802B2 (en) Aniline disulfide derivatives for treating allergic diseases
US20250026781A1 (en) Prodrugs of Neurosteroid Analogs and Uses Thereof
WO2002022074A2 (fr) Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
TW201513849A (zh) 藉由合成之帕那司托（ｐａｎａｘｙｔｒｉｏｌ）類似物之毒性下降
JP2002080368A (ja) 抗炎症薬
HK1050677B (en) Aniline disulfide derivatives for treating allergic diseases
JPWO2000003703A1 (ja) 新規なアレルギー疾患治療剤

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE CO-INVENTOR NAME FROM SHAEFER, JAMES TO SHAEFFER, JAMES

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired